Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01BGK
|
||||
Former ID |
DNC014022
|
||||
Drug Name |
1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529603] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H21NO3
|
||||
Canonical SMILES |
COC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2
|
||||
InChI |
1S/C17H21NO3/c1-20-16-13-21-17(18-16)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3
|
||||
InChIKey |
PLTPISAOEFIJFK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529603] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.